These biotech leaders are the ones bringing home the most bacon. [© Mariusz Prusaczyk - Fotolia.com]
#10. Merck & Co.
Kenneth C. Frazier, Chairman, President, and CEO
2011 Compensation: $13,347,652
2010 Compensation: $9,439,632
% Change: 41.1%
#9. Baxter International
Robert L. Parkinson Jr., Chairman and CEO
2011 Compensation: $14,065,479
2010 Compensation: $11,500,268
% Change: 22.3%
#8. Bristol-Myers Squibb
Lamberto Andreotti, CEO
2011 Compensation: $14,911,947
2010 Compensation: $11,770,880
% Change: 26.7%
#7. Gilead Sciences
John C. Martin, Chairman and CEO
2011 Compensation: $15,615,645
2010 Compensation: $14,244,388
% Change: 9.6%
#6. Novartis
Joseph Jimenez, CEO
2011 Compensation1: $15,881,621
2010 Compensation1: $11,828,828
% Change: 34.3%
1Converted to USD from CHF.
Total compensation includes salary, bonuses if any, stock awards, option awards, non-equity incentive plan compensation, annual charge to the pension fund plus non-qualified deferred compensation earnings, and all other forms of compensation. Figures were obtained from proxy statements and annual reports.